Reliq Health Technologies, Inc. · OTC:RQHTF
Reliq Health Technologies — Investor Presentation (October 2023)
16 slides from Reliq Health Technologies's investor presentation, October 2023
Slide 1: Investor Presentation October 2023
INVESTOR PRESENTATION October 2023 © Reliq Health Technologies Inc. 2023
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS Certain statements in this corporate presentation constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, fo
Slide 3: Reliq is a rapidly growing, profitable telemedicine company
Reliq is a rapidly growing, profitable telemedicine company that develops innovative Virtual Care SaaS solutions for the multibillion-dollar healthcare market • Reliq’s iUGO Care platform benefits everyone in the healthcare system: patients, clinicians and payors • Comprehensive turnkey solutions al
Slide 4: Recent Milestones
RECENT MILESTONES Signed contracts with: A physician network with over 300 locations across the United States. The network includes over 750 physicians and is expected to add over 100,000 new patients to the platform by the end of 2025. A leading US healthcare company with 75 locations in 8 States.
Slide 5: Recent Milestones
RECENT MILESTONES Signed contracts with: A large US health plan that operates Accountable Care Organizations (ACOs) in five States with more than 3,000 doctors and over 1,000,000 patients. The client is a subsidiary of one of the nation’s largest providers of hospital and healthcare services and a F
Slide 6: Metrics & Multiples
METRICS & MULTIPLES As of September 27, 2023 TSX-V: RHT STOCK LISTING OTC: RQHTF WKN: A2AJTB 52 Week High-Low $0.76 – $0.365 CAD Market Capitalization $93 Million CAD Current Revenue Multiple1 ~2X Projected Revenue for CY 2023 Recent Share Price $0.46 CAD Shares Outstanding (b/fd) 202 Million/215 Mi
Slide 7: Leadership Team
LEADERSHIP TEAM LISA CROSSLEY, PhD, P.ENG. MICHAEL FRANKEL, CFA DAVE McKAY, BSc CEO, Director CFO CTO • An experienced healthcare IT • Senior finance exec with a track record • Recognized expert in healthcare executive, previously CEO of VitalHub, of working with global tech companies technology, cy
Slide 8: The Problem
THE PROBLEM Chronic disease accounts for 80% of all healthcare spending COPD US HEALTHCARE COSTS = $4.4 TRILLION IN 2022 01 Heart • Chronic conditions account for >80% of all US healthcare Diabetes Disease costs, corresponding to $3.5 Trillion/year or 17% of US GDP POOR HEALTH OUTCOMES CHRONIC 02 •
Slide 9: iUGO Care's modular software solutions and Care Management services
iUGO Care’s modular software solutions and Care Management services allow clinicians to easily provide a wide range of virtual healthcare services to their at-risk patients Remote Patient Principal Care Telemedicine Wound Monitoring Management Care Chronic Care Behavioral Transitional Care Managemen
Slide 10: Use Case: CHF (Without iUGO Care)
USE CASE: CHF A patient with Congestive Heart Failure (CHF) has an episode of heart failure, causing an increased fluid load and a sudden weight gain of 2+ pounds in 24 hours Without iUGO Care • The patient forgets to weigh herself, forgets her previous weight or doesn’t remember that she is suppose
Slide 11: Use Case: CHF (With iUGO Care)
USE CASE: CHF A patient with Congestive Heart Failure (CHF) has an episode of heart failure, causing an increased fluid load and a sudden weight gain of 2+ pounds in 24 hours With iUGO Care • The patient’s care team immediately receives an automated alert notifying them of the weight change • The ph
Slide 12: Benefits of iUGO Care
BENEFITS OF iUGO CARE For patients: • Improves health outcomes • Reduces hospitalizations by >80% • Enhances quality of life For providers: • Creates new revenue streams • Avoids financial penalties The average practice can generate new revenue of >$400 USD per patient per month from CMS payments by
Slide 13: Revenue Growth
REVENUE GROWTH • Reliq’s revenues more than doubled YoY from FY2022 to FY2023 and are expected to more than double again in FY 2024. • Software & services revenues increased by >2.5X YoY from FY2022 to FY2023 and are expected to more than triple from FY2023 to FY2024. • Due to its rapidly accelerati
Slide 14: Growth Forecast
GROWTH FORECAST PANDEMIC ACCELERATING GROWTH GROSS MARGINS > 70% Growth Limited by COVID Focus on Client Acquisition EBITDA MARGINS > 40% 2021 2023 2024 2020 2022 POST-COVID RECOVERY ADDING LARGE CLIENTS NASDAQ, BIG DATA Initial Growth Phase Focus on Patient Adherence, Revenue: >$100 Million Maximiz
Slide 15: Trends and Tailwinds
TRENDS AND TAILWINDS $450 25 As the population ages and grows, the Number of Relevant Billing Codes • $400 number of chronic disease patients is steadily (USD per patient per month) $350 20 increasing Physician Revenue $300 • CMS has introduced financial penalties for 15 clinicians whose chronic dis
Slide 16: Thank You
THANK YOU CONTACT US: FOLLOW US ON: #406A-175 Longwood Rd S, linkedin.com/company/reliq-health-technologies-inc. Hamilton, ON, L8P 0A1 @reliqhealth +1 (888) 869-1362 info@reliqhealth.com © Reliq Health Technologies Inc. 2022
Reliq Health Technologies — Investor Presentation (October 2023) on 6ix